On Friday, AEON Biopharma Inc (AMEX: AEON) opened lower -5.93% from the last session, before settling in for the closing price of $0.78. Price fluctuations for AEON have ranged from $0.38 to $115.57 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -100.90% at the time writing. With a float of $9.11 million, this company’s outstanding shares have now reached $11.54 million.
AEON Biopharma Inc (AEON) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of AEON Biopharma Inc is 21.76%, while institutional ownership is 10.92%. The most recent insider transaction that took place on May 21 ’25, was worth 29,250. In this transaction Director of this company bought 60,000 shares at a rate of $0.49, taking the stock ownership to the 266,785 shares. Before that another transaction happened on May 20 ’25, when Company’s Director bought 60,000 for $0.51, making the entire transaction worth $30,360. This insider now owns 206,785 shares in total.
AEON Biopharma Inc (AEON) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around -100.90% per share during the next fiscal year.
AEON Biopharma Inc (AMEX: AEON) Trading Performance Indicators
Check out the current performance indicators for AEON Biopharma Inc (AEON). In the past quarter, the stock posted a quick ratio of 1.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.81, a number that is poised to hit -0.43 in the next quarter
Technical Analysis of AEON Biopharma Inc (AEON)
Analysing the last 5-days average volume posted by the [AEON Biopharma Inc, AEON], we can find that recorded value of 78060.0 was lower than the volume posted last year of 1.58 million. As of the previous 9 days, the stock’s Stochastic %D was 71.31%.
During the past 100 days, AEON Biopharma Inc’s (AEON) raw stochastic average was set at 53.64%, which indicates a significant decrease from 60.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0633 in the past 14 days, which was higher than the 0.0615 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7646, while its 200-day Moving Average is $10.6147. Now, the first resistance to watch is $0.7639. This is followed by the second major resistance level at $0.7962. The third major resistance level sits at $0.8145. If the price goes on to break the first support level at $0.7133, it is likely to go to the next support level at $0.6950. Should the price break the second support level, the third support level stands at $0.6627.
AEON Biopharma Inc (AMEX: AEON) Key Stats
There are currently 11,644K shares outstanding in the company with a market cap of 8.52 million. Presently, the company’s annual sales total 0 K according to its annual income of 42,010 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,640 K.
